171 related articles for article (PubMed ID: 34533565)
21. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
Wang S; Chen J; Li H; Qi X; Liu X; Guo X
Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
[No Abstract] [Full Text] [Related]
22. Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63-Integrin β1 Interaction.
Takawale A; Zhang P; Patel VB; Wang X; Oudit G; Kassiri Z
Hypertension; 2017 Jun; 69(6):1092-1103. PubMed ID: 28373589
[TBL] [Abstract][Full Text] [Related]
23. Sexual dimorphism of liver metastasis by murine pancreatic neuroendocrine tumors is affected by expression of complement C5.
Contractor T; Kobayashi S; da Silva E; Clausen R; Chan C; Vosburgh E; Tang LH; Levine AJ; Harris CR
Oncotarget; 2016 May; 7(21):30585-96. PubMed ID: 27105526
[TBL] [Abstract][Full Text] [Related]
24. Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1.
Gerin I; Louis GW; Zhang X; Prestwich TC; Kumar TR; Myers MG; Macdougald OA; Nothnick WB
Endocrinology; 2009 Apr; 150(4):1697-704. PubMed ID: 19036876
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
[TBL] [Abstract][Full Text] [Related]
26. Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans.
Meissburger B; Stachorski L; Röder E; Rudofsky G; Wolfrum C
Diabetologia; 2011 Jun; 54(6):1468-79. PubMed ID: 21437772
[TBL] [Abstract][Full Text] [Related]
27. The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.
Nakopoulou L; Giannopoulou I; Lazaris ACh; Alexandrou P; Tsirmpa I; Markaki S; Panayotopoulou E; Keramopoulos A
APMIS; 2003 Nov; 111(11):1027-36. PubMed ID: 14629269
[TBL] [Abstract][Full Text] [Related]
28. Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast.
Wieczorek E; Galicki M; Tomasik B; Krol M; Jablonska E; Fendler W; Gromadzinska J; Morawiec Z; Wasowicz W; Reszka E
Int J Biol Markers; 2016 Jul; 31(3):e309-16. PubMed ID: 27032379
[TBL] [Abstract][Full Text] [Related]
29. A fine balance between CCNL1 and TIMP1 contributes to the development of breast cancer cells.
Peng L; Yanjiao M; Ai-guo W; Pengtao G; Jianhua L; Ju Y; Hongsheng O; Xichen Z
Biochem Biophys Res Commun; 2011 Jun; 409(2):344-9. PubMed ID: 21586274
[TBL] [Abstract][Full Text] [Related]
30. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo.
Rigg AS; Lemoine NR
Cancer Gene Ther; 2001 Nov; 8(11):869-78. PubMed ID: 11773977
[TBL] [Abstract][Full Text] [Related]
31. LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer.
Zheng B; Qu J; Ohuchida K; Feng H; Chong SJF; Yan Z; Piao Y; Liu P; Sheng N; Eguchi D; Ohtsuka T; Mizumoto K; Liu Z; Pervaiz S; Gong P; Nakamura M
Theranostics; 2020; 10(22):10274-10289. PubMed ID: 32929348
[No Abstract] [Full Text] [Related]
32. Prevention of early liver metastasis after pancreatectomy by perioperative administration of a nuclear factor-κB inhibitor in mice.
Saito N; Uwagawa T; Hamura R; Takada N; Sugano H; Shirai Y; Shiba H; Ohashi T; Yanaga K
Surgery; 2019 Dec; 166(6):991-996. PubMed ID: 31353078
[TBL] [Abstract][Full Text] [Related]
33. Tissue Inhibitor of Metalloproteinase 1 Influences Vascular Adaptations to Chronic Alterations in Blood Flow.
Mandel ER; Uchida C; Nwadozi E; Makki A; Haas TL
J Cell Physiol; 2017 Apr; 232(4):831-841. PubMed ID: 27430487
[TBL] [Abstract][Full Text] [Related]
34. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
35. [Gene expression of MMP1 and TIMP1 in lung cancer detected with a cDNA microarray technique].
Ouyang QC; Hu CP; Liang QH
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):227-8. PubMed ID: 14653073
[TBL] [Abstract][Full Text] [Related]
36. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.
Gong YL; Xu GM; Huang WD; Chen LB
J Surg Oncol; 2000 Feb; 73(2):95-9. PubMed ID: 10694645
[TBL] [Abstract][Full Text] [Related]
37. TIMP1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer.
Yang L; Jiang Q; Li DZ; Zhou X; Yu DS; Zhong J
Aging (Albany NY); 2019 Oct; 11(20):8998-9012. PubMed ID: 31639773
[TBL] [Abstract][Full Text] [Related]
38. Plasma TIMP1 level is a prognostic factor in patients with liver metastases.
Bunatova K; Pesta M; Kulda V; Topolcan O; Vrzalova J; Sutnar A; Treska V; Pecen L; Liska V
Anticancer Res; 2012 Oct; 32(10):4601-6. PubMed ID: 23060593
[TBL] [Abstract][Full Text] [Related]
39. Variability of X chromosome inactivation: effect on levels of TIMP1 RNA and role of DNA methylation.
Anderson CL; Brown CJ
Hum Genet; 2002 Mar; 110(3):271-8. PubMed ID: 11935340
[TBL] [Abstract][Full Text] [Related]
40. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.
Illemann M; Eefsen RH; Bird NC; Majeed A; Osterlind K; Laerum OD; Alpízar-Alpízar W; Lund IK; Høyer-Hansen G
Mol Carcinog; 2016 Feb; 55(2):193-208. PubMed ID: 25594187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
